VICTORY CAPITAL MANAGEMENT INC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-01 12:25 pm Sale |
2021-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
VICTORY CAPITAL MANAGEMENT INC | 8,828 0.010% |
-2,719,209 (-99.68%) |
Filing |
| 2021-02-02 3:13 pm Sale |
2020-12-31 | 13G | CytomX Therapeutics, Inc. CTMX |
VICTORY CAPITAL MANAGEMENT INC | 2,728,037 7.110% |
-85,414 (-3.04%) |
Filing |